BIOMED Home >> | Who We Are | Faculty | Research | Undergraduate Program | Graduate Programs | Students | Alumni  | Contact Us

October 11, 2005

"InfraScan to present at Medtech Insight's "Investment In Innovation" Boston Conference."

BOSTON--(BUSINESS WIRE)--Oct. 5, 2005--InfraScan Inc., which is developing a rapid, accessible and affordable method to diagnose bleeding in the brain to improve the treatment of head injury, announces today that it is presenting at 10:35 a.m. on October 11 at Medtech Insight's "Investment In Innovation (In3) BOSTON: A Preview of Early-Stage Medical Technology Companies" Conference, taking place October 10-11, 2005 at The Westin Copley Place Hotel in Boston, MA.

From the time a person experiences severe head trauma at the scene of an accident paramedics and physicians have one "golden hour" to define what type of surgical intervention is necessary to save the patient's life. Realizing the importance of finding hematoma as soon as possible, a team of Drexel University biomedical engineers are working with the patented work in near-infrared based brain imaging of pioneer Dr. Britton Chance, Eldridge Reeves Johnson University Professor Emeritus at the University of Pennsylvania School of Medicine, to develop and market the InfraScanner(TM), a handheld device that medical professionals can use to detect brain hematoma at the accident scene.

"The InfraScanner(TM) promises to be a fast, accurate and affordable traumatic brain injury triage solution," said Dr. Banu Onaral, director of Drexel's School of Biomedical Engineering, Science and Health Systems, who is leading the Drexel team. "The user-friendly device maps out the location of the hematoma with graphics onto a PDA screen, and can assist paramedics and emergency room personnel in attending to those injured in traffic and sports accidents, falls and on the battlefield."

The InfraScanner(TM) started pilot clinical tests in the Neurosurgery department of the Hospital of the University of Pennsylvania and is about to begin multicenter clinical trials. Pending FDA approval, the device will be available in the U.S. as early as 2006.

For the full story, please visit



Proper Lab Attire and Protection

Senior Design Proposal Presentations

Alumni Networking Event for BME's

Why Wearables Matter for Medtech

A 3-D Heart Simulator

NEWS Archive

Phone 215.895.2215 | Fax 215.895.4983 | Email
Copyright 2015, Drexel University, All Rights Reserved.